Back to GALE Stock Lookup

Galena Biopharma (GALE) – Corporate News

Oct 14, 2014 07:06 AM Galena Biopharma (GALE) Receives NoA from Japanese Patent Office for NeuVax
Oct 8, 2014 07:06 AM Galena Biopharma (GALE) Receives NeuVax-Related Patent Notice of Allowance from USPTO
Sep 25, 2014 04:17 PM Galena Biopharma (GALE) Releases Special Committee Report
Sep 9, 2014 07:05 AM Galena Biopharma (GALE) Commences Dosing of GALE-401 Phase 2
Jul 22, 2014 09:12 AM Roth Capital Raises PT on Galena (GALE) to $8 Following Zuplenz Licensing News
Jul 22, 2014 07:13 AM Galena Biopharma (GALE) Enters Licensing Agreement for Zuplenz Oral Soluable Film
Jul 1, 2014 07:07 AM Galena Biopharma (GALE) Receives Notice of Allowance for NeuVax Patent
Jun 17, 2014 07:06 AM Galena Biopharma's (GALE) GALE-301 Phase 2a is Now Fully Enrolled
May 21, 2014 07:06 AM Galena Biopharma (GALE) to Present GALE-301 Phase 1 Data at ASCO
Apr 28, 2014 07:07 AM Galena Biopharma (GALE) Will Receive DoD Grant for New NeuVax Trial
Apr 3, 2014 07:06 AM GALENA BIOPHARMA (GALE) Presenting at 13th Annual Needham Healthcare Conference
Mar 17, 2014 05:13 PM Galena Biopharma (GALE) Discloses SEC Investigation
Mar 3, 2014 08:10 AM Galena Biopharma (GALE) Launches Galena Patient Services Support Program
Feb 28, 2014 07:20 AM Galena (GALE) Receives Patent for NeuVax in Australia
Jan 17, 2014 07:06 AM Galena Biopharma (GALE) Plans Presentation at Noble Financial Capital Markets 'X' Equity Conference
Jan 14, 2014 07:13 AM Galena Biopharma (GALE) Enters NeuVax Licensing Agreement with Dr. Reddy's (RDY)
Jan 13, 2014 07:37 AM Galena Biopharma (GALE) Acquires GALE-401 Rights Owner, Mills Pharmaceuticals
Jan 7, 2014 07:05 AM Galena Biopharma (GALE) Enrolls First Patient in GALE-301 Phase 2
Nov 11, 2013 07:07 AM Galena Biopharma (GALE) Presents Data from FBP Vaccine Phase 1 at SITC
Oct 7, 2013 07:16 AM Galena Biopharma (GALE) to Present Data from NeuVax Phase 2
Oct 3, 2013 07:07 AM Galena Biopharma (GALE) Announces Launch of Abstral Tabs in U.S.
Sep 13, 2013 09:21 AM Galena Biopharma (GALE) Prices 17.5M Offering at $2/Unit
Sep 3, 2013 07:07 AM Galena Biopharma (GALE) Initiates RELIEF to Evaluate Abstral as BTcP
Jun 3, 2013 07:07 AM Galena Biopharma (GALE) Issues Update to FBP-E39 Phase 1/2 at ASCO
Dec 18, 2012 09:01 AM Galena Biopharma (GALE) Prices 15.2M Offering at $1.60/Unit
Dec 7, 2012 07:12 AM Galena (GALE) Presents New Data on SN-33, NeuVax Phase 1/2
Dec 6, 2012 07:08 AM Galena Biopharma (GALE), Leica Biosystems Enter NeuVax Partnership
Dec 4, 2012 07:08 AM Galena Biopharma (GALE) Enters NeuVax Commercialization Agreement w/ Teva (TEVA)
Oct 26, 2012 07:09 AM Galena Biopharma (GALE) Presents Data from NeuVax Phase 1/2 in Breast Cancer
Aug 13, 2012 07:10 AM Galena Biopharma (GALE) Gets Japanese Patent for FBP Peptide Variants
Jul 18, 2012 07:13 AM Galena Biopharma (GALE) Receives NeuVax Patent
Jun 5, 2012 07:08 AM Galena Biopharma (GALE) NeuVax Continues w/ Strong Safety Profile
Jun 4, 2012 07:07 AM Galena Biopharma (GALE) Updates from NeuVax Phase 1/2 Following Booster Inoculations; Will Present at ASCO
May 23, 2012 11:45 AM Galena Biopharma (GALE) Withdraws S-3 Registration; Shares Moving Higher
May 1, 2012 07:06 AM Galena Biopharma (GALE) Gets U.S. Patent Allowance for FBP Peptide Variants
Apr 16, 2012 07:05 AM Galena Biopharma (GALE) Closes 9.75M Common Offering
Apr 5, 2012 08:41 AM Galena (GALE) Prices 8.5M Offering at $1.50/Share
Mar 20, 2012 07:15 AM Galena Biopharma (GALE) Receives Notice of Allowance for US Patent Related to NeuVax
Feb 14, 2012 07:06 AM Galena Biopharma (GALE) Initiates E39 Phase 1/2 in Two Gynecological Cancers
Jan 20, 2012 07:06 AM Galena Biopharma (GALE) Initiates NeuVax Phase 3
Dec 9, 2011 07:06 AM Galena Biopharma (GALE) Updates on NeuVax w/ Herceptin Phase 2 Design
Dec 7, 2011 09:01 AM Shares of Galena Biopharma (GALE) Trade up 22% on 5 Year NeuVax Efficacy Data
Dec 7, 2011 07:06 AM Galena (GALE) Reports Statistically Significant Data for NeuVax from Phase 2
Nov 28, 2011 08:24 AM Shares of Galena Biopharma (GALE) Trade Up on Collaboration With Genentech/Roche & The Henry M. Jackson Foundation
Nov 18, 2011 07:07 AM Galena Biopharma (GALE) Will Make Two E75-Related Presentations at Upcoming CTRC-AACR Symposium

Back to GALE Stock Lookup